Back to FDA Applications sponsored by MILLENNIUM PHARMS

FDA Drug Application 021602 by MILLENNIUM PHARMS

Application Number021602
Application Type New Drug Application
Sponsor ApplicantMILLENNIUM PHARMS
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Priority
Orphan CodeV


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP05/13/2003N5630000   http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021602lbl.pdf 5/13/2003
AP05/13/2003N5639000   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21602ltr.pdf 5/16/2003
AP05/13/2003N6654000   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21602_Velcade.cfm 9/25/2003
AP05/13/2003N7221000   http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm106494.htm 12/12/2003
AP05/25/2004SLR8823004   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21602slr004ltr.pdf 6/1/2004
AP03/25/2005SE111288006   http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021602s006lbl.pdf 3/25/2005
AP03/25/2005SE111311006   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/21602s006ltr.pdf 3/30/2005
AP012/8/2005SLR13274007   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021602s007ltr.pdf 12/15/2005
AP05/31/2006SLR14198009   http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021602s008,s009.pdf 6/1/2006
AP05/31/2006SLR14217009   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021602s008, s009LTR.pdf 6/2/2006
AP012/8/2006SE115452010   http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021602s010lbl.pdf 12/8/2006
AP012/8/2006SE115552010   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021602s010ltr.pdf 12/28/2006
AP012/8/2006SE127476010   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021602_s010_velcade.pdf 1/7/2011
AP010/10/2007SE818208013   http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021602s013lbl.pdf 10/10/2007
AP010/10/2007SE818235013   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021602s013ltr.pdf 10/15/2007
AP06/20/2008SE120054015   http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021602s015lbl.pdf 6/23/2008
AP06/20/2008SE120058015   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021602se1-015ltr.pdf 6/24/2008
AP06/20/2008SE130810015   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/021602Orig1s015.pdf 10/10/2011
AP04/24/2009SCM22401018   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021602s018ltr.pdf 5/4/2009
AP012/30/2009SE824427019   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021602s019s020ltr.pdf 1/5/2010
AP012/30/2009SE824497019   http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021602s019s020lbl.pdf 1/12/2010
AP012/30/2009SE824426020   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021602s019s020ltr.pdf 1/5/2010
AP012/30/2009SE824498020   http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021602s019s020lbl.pdf 1/12/2010
AP012/3/2010SLR27161023   http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021602s023lbl.pdf 12/4/2010
AP012/3/2010SLR27254023   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021602s023ltr.pdf 12/7/2010
AP01/23/2012SE331489027   http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021602s027lbl.pdf 1/23/2012
AP01/23/2012SE331512027   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021602s027ltr.pdf 1/25/2012
AP04/7/2011SLR       
AP011/1/2011SLR30485029   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021602s029,s030ltr.pdf 11/3/2011
AP011/1/2011SLR30498029   http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021602s029s030lbl.pdf 11/4/2011
AP011/1/2011SE830484030   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021602s029,s030ltr.pdf 11/3/2011
AP011/1/2011SE830499030   http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021602s029s030lbl.pdf 11/4/2011
AP010/26/2012SLR34185031   http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021602s031s032lbl.pdf 10/26/2012
AP010/26/2012SLR34193031   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021602Orig1s031,s032ltr.pdf 10/29/2012
AP010/26/2012SLR34186032   http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021602s031s032lbl.pdf 10/26/2012
AP010/26/2012SLR34194032   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021602Orig1s031,s032ltr.pdf 10/29/2012
AP04/1/2013SCM       
AP08/2/2013SCM       
AP08/5/2013SCM       
AP03/13/2014SCM       
AP08/8/2014SE840201038   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/021602Orig1s038ltr.pdf 8/12/2014
AP08/8/2014SE840208038   http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021602s038lbl.pdf 8/12/2014
AP09/8/2014SCM       
AP010/8/2014SE840738040   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/021602Orig1s040ltr.pdf 10/9/2014
AP010/8/2014SE840743040   http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021602s040lbl.pdf 10/9/2014
AP08/20/2015SCM       
AP09/14/2015SE843886042   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021602Orig1s042ltr.pdf 9/16/2015
AP09/14/2015SE843973042   http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021602s042lbl.pdf 9/23/2015




Back to FDA Applications sponsored by MILLENNIUM PHARMS